| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1438391-30-0 | 3-[3-[2-(1-Piperidinyl)ethoxy]phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole hydrochloride (1:1) | C22H24N6O.HCl |
| 1438391-33-3 | 4-Bromo-6-(1,1-dimethylethyl)dibenzofuran | C16H15BrO |
| 1438416-21-7 | 2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate | C22H21Cl2N3O4 |
| 1438427-35-0 | 6-Bromo-5H-benzofuro[3,2-c]carbazole | C18H10BrNO |
| 1438492-26-2 | (2S,2'S)-N,N'-(1,4-Piperazinediyldi-3,1-propanediyl)bis[2-amino-5-[(aminoiminomethyl)amino]pentanamide] | C22H48N12O2 |
| 1438881-19-6 | (2S)-3-Phenyl-N1-[5,6,7,8-tetrahydro-2-(4-pyridinyl)[1]benzothieno[2,3-d]pyrimidin-4-yl]-1,2-propanediamine | C24H25N5S |
| 1439328-85-4 | Zearalenone 4-Sulfate Ammonium Salt | C18H25NO8S |
| 1439329-55-1 | Zearalenone Disulfate Diammonium Salt | C18H28N2O11S2 |
| 1439373-14-4 | (2S)-2-(Fluoromethyl)-4-morpholinecarboxylic acid 1,1-dimethylethyl ester | C10H18FNO3 |
| 1439373-55-3 | (2S)-2-Morpholinecarboxylic acid hydrochloride | C5H9NO3.HCl |
| 1439399-58-2 | CB 839 | C26H24F3N7O3S |
| 1439901-97-9 | 6-Amino-9-[(3R)-1-(2-butynoyl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one hydrochloride | C25H22N6O3.HCl |
| 1439903-69-1 | L-Alanine, 2-ethylbutyl ester, 4-methylbenzenesulfonate (1:1) | C9H19NO2 .C7H8O3S |
| 1439934-41-4 | 2-[[5-Chloro-2-[[4-(1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]-N-methylbenzamide | C22H24ClN7O |
| 1440209-96-0 | N1-Hydroxy-N3-(2-phenylethyl)-1,3-benzenedicarboxamide | C16H16N2O3 |
| 1440526-53-3 | 2-Bromo-4-benzothiazolecarboxylic acid methyl ester | C9H6BrNO2S |
| 1440898-61-2 | Deltarasin | C40H37N5O |
| 1440898-82-7 | Deltarasin hydrochloride (1:?) | C40H37N5O.x(HCl) |
| 1440961-11-4 | Citalopram EP Impurity C Oxalate | C22H21FN2O6 |
| 1441161-43-8 | 2-(Aminomethyl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C10H21N3O2 |
| 1441177-16-7 | (2R)-2-(Aminomethyl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C10H21N3O2 |
| 1441177-17-8 | (3R)-3-(Aminomethyl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C10H21N3O2 |
| 1441177-21-4 | (3S)-3-(Aminomethyl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C10H21N3O2 |
| 1441177-22-5 | (2S)-2-(Aminomethyl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C10H21N3O2 |
| 1441190-66-4 | Cyclic guanosine monophosphate-adenosine monophosphate | C20H24N10O13P2 |
| 1441392-27-3 | (3R,4R)-3-Amino-4-fluoro-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | C9H17FN2O2 |
| 1441670-89-8 | (6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester | C27H26BrF2N3O2 |
| 1441673-92-2 | (6S)-5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid 5-(1,1-dimethylethyl) ester potassium salt (1:1) | C12H18NO4.K |
| 1441674-54-9 | Ledipasvir compd. with acetone | C49H54F2N8O6.C3H6O |
| 1442400-65-8 | Azilsartan Impurity L | C24H22N4O3 |
| 1442400-68-1 | Azilsartan Impurity K | C23H16N4O5 |
| 1442433-71-7 | 9-Mesityl-10-methylacridinium tetrafluoroborate | C23H22BF4N |
| 1442471-26-2 | Ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate | C10H11BrFNO2 |
| 1442472-39-0 | Ripretinib | C24H21BrFN5O2 |
| 1442648-14-7 | 8-Bromo-2-dibenzofurancarbonitrile | C13H6BrNO |
| 1442684-77-6 | N-[6'-(2-Hydroxy-2-methylpropoxy)-4-[(5-methyl-3-pyridinyl)oxy][3,3'-bipyridin]-6-yl]-N'-methylurea | C22H25N5O4 |
| 1442873-91-7 | (4S,5R,6R)-5-Acetylamino-4-azido-6-[(S)-methoxy[(4R)-2-oxo-1,3-dioxolane-4-yl]methyl]-5,6-dihydro-4H-pyran-2-carboxylic acid methyl ester | C14H18N4O8 |
| 1443034-67-0 | Prasugrel Acetyl Impurity | C18H18FNO3S |
| 1443048-86-9 | 3,10-Dihydro-2,3-diphenylpyrrolo[3,2-a]carbazole | C26H18N2 |
| 1443049-83-9 | 2-(3'-Chloro[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine | C27H18ClN3 |
| 1443049-84-0 | 2-(3'-Chloro[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine | C27H18ClN3 |
| 1443049-85-1 | 2-(4'-Chloro[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine | C27H18ClN3 |
| 1443049-86-2 | 2-(4'-Chloro[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine | C27H18ClN3 |
| 1443118-71-5 | Axitinib Impurity 35 | C15H12IN3O2S |
| 1443118-72-6 | N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-[2-(2-pyridinyl)ethyl]-1H-indazol-6-yl]thio]benzamide | C29H25N5OS |
| 1443118-73-7 | N-Methyl-2-[[3-[2-(2-pyridinyl)ethyl]-1H-indazol-6-yl]thio]benzamide | C22H20N4OS |
| 1443120-32-8 | 4,8-Di(5-(2-butyloctyl)thiophen-2-yl)-benzo[1,2-b:4,5-b']dithiophene | C42H58S4 |
| 1443139-14-7 | 2-[(6-Bromo-2-methyl-4-quinolinyl)oxy]-N-(phenylmethyl)acetamide | C19H17BrN2O2 |
| 1443149-12-9 | Dextromethorphan-d3 Hydrobromide | C18H23D3BrNO |
| 1443211-72-0 | Eleclazine | C21H16F3N3O3 |